ADMA Biologics Inc Common Stock Earnings Dividend

ADMA Biologics Inc Common Stock’s revenue jumped 1.98% since last year same period to $124.4Mn in the Q2 2026. On a quarterly growth basis, ADMA Biologics Inc Common Stock has generated 8.65% jump in its revenue since last 3-months.

ADMA Biologics Inc Common Stock’s net profit jumped 10.53% since last year same period to $37.82Mn in the Q2 2026. On a quarterly growth basis, ADMA Biologics Inc Common Stock has generated -16.56% fall in its net profits since last 3-months.

ADMA Biologics Inc Common Stock’s net profit margin jumped 8.39% since last year same period to 30.4% in the Q2 2026. On a quarterly growth basis, ADMA Biologics Inc Common Stock has generated -23.2% fall in its net profit margins since last 3-months.

ADMA Biologics Inc Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.16 - a -20% fall from last quarter’s estimates.

ADMA Biologics Inc Common Stock’s earning per share (EPS) estimates for the current year stand at 0.16.

ADMA Biologics Inc Common Stock’s earning per share (EPS) jumped 14.29% since last year same period to 0.16 in the Q2 2026. This indicates that the ADMA Biologics Inc Common Stock has generated 14.29% annual rate of jump in its earning per share (EPS) in the last 4 quarters.